Introduction
Near patient testing, or "point-of-care" testing as it is widely called, is difficult to define well. Clearly, it refers to testing which is not performed in a central hospital laboratory but is performed close to the patient. A broad definition would include that testing which is performed in decentralised units such as a critical care unit, an emergency room or an operating room. A narrow definition would only include those tests which are done physically next to the patient or by the patients themselves. This article will mostly concentrate on the narrow definition. The types of testing will be defined and then the advantages and disadvantages will be discussed.
One of the first commercially available examples of near patient testing was the urine glucose dipstick, which was introduced several decades ago. This allowed a health care worker on the floor to test for the presence of glucose in a patient's urine. This was followed later by a dipstick which allowed testing for Home pregnancy testing has become a widespread business and this is how most women nowadays check to see whether they are pregnant. Although these tests are easy to carry out, there are still pitfalls that can occur due to misreading or misinterpreting instructions. Hicks and Iosefsohn2 in a study using lay persons demonstrated that about 9-5-12% of home pregnancy test results were incorrect, even among well-motivated subjects.
The use of glucose meters for diabetics at home has become standard practice in the United States and many other countries. This article will not deal with the benefits of this, but suffice it to say that this approach offers a great deal of convenience to the patient. Those meters which allow the physician to be sure that the patient is actually doing the monitoring are clearly the best. It is critical that the patient is extremely well instructed in the use ofglucose meters and that their competency is checked from time to time. A new profession that has ,7 Clin Pathol 1996;49: [191] [192] [193] sprung up in recent years is that of the diabetic educator. This person spends much time teaching patients the correct use of glucose meters and when it is necessary to contact the physician.
Bedside testing Technology using "dry testing" or advanced microchips has led to extremely precise and accurate results and great stability of equipment. This has hastened the introduction of bedside testing.
Bedside monitoring of whole blood glucose has been used for many years and yet it is still difficult to control the quality of this testing in the hospital setting, a problem which has been the subject of many recent papers.?5 A consensus conference6 has recommended that a target for future glucose monitors should be no more than a 5% analytical error. Few, if any, current monitors can meet this standard.3 It has been shown4 that there is a higher variance ofprecision when multiple operators, controls and test strips are used. It was also noted that results for the same sample could vary by 33%. It is very important that each institution sets standards for acceptability of instrument performance and that evaluations should take place in the hands of those personnel who will be using them and not by laboratory personnel. Weiner6 points out the difficulty that there is a difference in the volume of red cells from one blood sample to another and that the results with some methods are affected by these differences. The question now arises as to whether biosensors for blood glucose will supplant the traditional approach.
A biosensor is an analytical device that uses a biodetector such as an enzyme, antibody, microorganism, etc., to recognise the analyte directly without the need for specimen processing. Recently, technology has advanced to the stage that electrochemical biosensors for glucose can perform reliable measurements in undiluted whole blood. However, some problems remain in that the concentrations of glucose measured are often about 7% higher than traditional measurements due to the water content of the sample in diluted methods. We have recently introduced the Triage System (Biosite Diagnostics, San Diego, Cali-fornia, USA) for testing for drugs of abuse, which is ideal for screening in the Accident and Emergency department. This panel for drugs of abuse uses a rapid multiple immunoassay system. All positive results are confirmed by gas chromatography/mass spectrometry and so far, we have had very few false negative results.
The issue of specimen handling is not of concern except to ensure that a good flow of blood is initiated and the first drop discarded before the blood is collected. This avoids contamination by tissue fluid. In all bedside testing devices, the blood is introduced immediately and, therefore, evaporation of the specimen is less of a problem than using traditional instrumentation.
In order to set up a good bedside testing programme in a hospital, it is essential to have a "point-of-care" testing coordinator ( The clear advantages of bedside testing are that more rapid results can be obtained and, if the nurse or other health care worker currently on the floor does the testing, there are fewer people interacting with the patient. Well defined studies need to be done to see whether stabilisation of the patient and clinical outcomes improve and also whether length of stay decreases and in turn, health care costs decrease. The question of accuracy seems to be moot as many studies including our own have shown the quality of results with today's technology is excellent. Control by the central laboratory is important and can be realised by being networked with the laboratory information system.
It is my belief that "point-of-care" testing in the hospital is here to stay and that by the end of the next decade, the majority of routine or screening tests will be done in this way. This is because it provides convenience for both the patient and the physician. The hospital laboratory of the future could well be the focus for esoteric and sophisticated testing and all other testing would be done at the bedside or in the physician's office, off site.
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